Toxoplasmosis can be life threatening to cardiac transplant recipients. Those at greatest risk are Toxoplasma specific antibody negative recipients who are exposed to the parasite for the first time when receiving viable cysts in the organ graft of seropositive donors. About 60% of such mismatches result in severe toxoplasma infection, although this incidence is reduced significantly when prophylaxis with pyrimethamine is given.' Primary toxoplasma infection originating in the transplanted heart can be diagnosed by serological or histological methods. The infected recipient usually has detectable specific IgM and rising titres of IgG 
